UNITED STATES
FORM 10-Q
|
(Mark One)
|
||
|
[X]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
| For the quarterly period ended September 30, 2004 | ||
| OR | ||
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
| For the transition period from to | ||
Commission file number: 1-32258
Reynolds American Inc.
| North Carolina | 20-0546644 | |
|
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) |
401 North Main Street
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES þ NO o
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). YES o NO þ
Indicate the number of shares outstanding of each of the issuers classes of common stock as of the latest practicable date: 147,555,338 shares of common stock, par value $.01 per share, as of October 15, 2004
INDEX
PART I Financial Information
| Item 1. | Financial Statements |
REYNOLDS AMERICAN INC.
| For the | For the | |||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||
| September 30, | September 30, | |||||||||||||||||
| 2004 | 2003 | 2004 | 2003 | |||||||||||||||
|
Net
sales1
|
$ | 1,866 | $ | 1,384 | $ | 4,436 | $ | 4,033 | ||||||||||
|
Costs and expenses:
|
||||||||||||||||||
|
Cost of products sold1, 2
|
1,139 | 814 | 2,647 | 2,418 | ||||||||||||||
|
Selling, general and administrative expenses
|
377 | 313 | 970 | 1,028 | ||||||||||||||
|
Amortization expense
|
11 | | 11 | | ||||||||||||||
|
Restructuring and asset impairment charges
|
(7 | ) | 310 | (25 | ) | 365 | ||||||||||||
|
Goodwill and trademark impairment charges
|
| 3,590 | | 3,590 | ||||||||||||||
|
Operating income (loss)
|
346 | (3,643 | ) | 833 | (3,368 | ) | ||||||||||||
|
Interest and debt expense
|
21 | 25 | 62 | 90 | ||||||||||||||
|
Interest income
|
(7 | ) | (6 | ) | (16 | ) | (23 | ) | ||||||||||
|
Other (income) expense, net
|
(1 | ) | 2 | 4 | (4 | ) | ||||||||||||
|
Income (loss) from continuing operations
before income taxes
|
333 | (3,664 | ) | 783 | (3,431 | ) | ||||||||||||
|
Provision for (benefit from) income taxes
|
43 | (213 | ) | 221 | (121 | ) | ||||||||||||
|
Income (loss) from continuing
operations
|
290 | (3,451 | ) | 562 | (3,310 | ) | ||||||||||||
|
Discontinued operations:
|
||||||||||||||||||
|
Gain on sale of discontinued businesses, net of
income taxes
|
| | 1 | | ||||||||||||||
|
Income (loss) before extraordinary
item
|
290 | (3,451 | ) | 563 | (3,310 | ) | ||||||||||||
|
Extraordinary item gain on acquisition
|
49 | | 49 | | ||||||||||||||
|
Net income (loss)
|
$ | 339 | $ | (3,451 | ) | $ | 612 | $ | (3,310 | ) | ||||||||
|
Basic income (loss) per share:
|
||||||||||||||||||
|
Income (loss) from continuing operations
|
$ | 2.29 | $ | (41.31 | ) | $ | 5.70 | $ | (39.55 | ) | ||||||||
|
Gain on sale of discontinued businesses
|
| | .01 | | ||||||||||||||
|
Extraordinary item gain on acquisition
|
.38 | | .50 | | ||||||||||||||
|
Net income (loss)
|
$ | 2.67 | $ | (41.31 | ) | $ | 6.21 | $ | (39.55 | ) | ||||||||
|
Diluted income (loss) per share:
|
||||||||||||||||||
|
Income (loss) from continuing operations
|
$ | 2.28 | $ | (41.31 | ) | $ | 5.66 | $ | (39.55 | ) | ||||||||
|
Gain on sale of discontinued businesses
|
| | .01 | | ||||||||||||||
|
Extraordinary item gain on acquisition
|
.38 | | .49 | | ||||||||||||||
|
Net income (loss)
|
$ | 2.66 | $ | (41.31 | ) | $ | 6.16 | $ | (39.55 | ) | ||||||||
|
Dividends declared per share
|
$ | 0.95 | $ | 0.95 | $ | 2.85 | $ | 2.85 | ||||||||||
| 1 | Excludes excise taxes of $525 million and $405 million for the three months ended September 30, 2004 and 2003, respectively, and $1.3 billion and $1.2 billion for the nine months ended September 30, 2004 and 2003, respectively. |
| 2 | Includes settlement expense of $652 million and $500 million for the three months ended September 30, 2004 and 2003, respectively, and $1.6 billion and $1.5 billion for the nine months ended September 30, 2004 and 2003, respectively. |
See Notes to Condensed Consolidated Financial Statements
3
REYNOLDS AMERICAN INC.
| For the | ||||||||||
| Nine Months Ended | ||||||||||
| September 30, | ||||||||||
| 2004 | 2003 | |||||||||
|
Cash flows from (used in) operating
activities:
|
||||||||||
|
Net income (loss)
|
$ | 612 | $ | (3,310 | ) | |||||
|
Less gain from discontinued operations
|
(1 | ) | | |||||||
|
Adjustments to reconcile to net cash flows from
(used in)
|
||||||||||
|
operating activities net of effects of
acquisition:
|
||||||||||
|
Depreciation and amortization
|
83 | 118 | ||||||||
|
Goodwill and trademark impairment charges
|
| 3,590 | ||||||||
|
Restructuring and asset impairment charges, net
of cash payments
|
(165 | ) | 319 | |||||||
|
Deferred income tax benefit
|
(125 | ) | (308 | ) | ||||||
|
Extraordinary item gain on acquisition
|
(49 | ) | | |||||||
|
Other working capital items
|
53 | 79 | ||||||||
|
Tobacco settlement and related expenses
|
71 | 8 | ||||||||
|
Retirement benefits
|
(75 | ) | 107 | |||||||
|
Other, net
|
85 | 4 | ||||||||
|
Net cash flows from operating activities
|
489 | 607 | ||||||||
|
Cash flows from (used in) investing
activities:
|
||||||||||
|
Capital expenditures
|
(50 | ) | (35 | ) | ||||||
|
Acquisition, net of cash acquired
|
204 | (9 | ) | |||||||
|
Distribution from (investment in) equity investees
|
5 | (20 | ) | |||||||
|
Purchases of short-term investments
|
(1 | ) | (4 | ) | ||||||
|
Proceeds from sale of short-term investments
|
| 492 | ||||||||
|
Purchases of long-term investments
|
(10 | ) | | |||||||
|
Proceeds from the sale of business
|
| 6 | ||||||||
|
Other, net
|
(38 | ) | 1 | |||||||
|
Net cash flows from investing activities
|
110 | 431 | ||||||||
|
Cash flows from (used in) financing
activities:
|
||||||||||
|
Repurchase of common stock
|
(38 | ) | (72 | ) | ||||||
|
Repayment of long-term debt
|
(56 | ) | (741 | ) | ||||||
|
Dividends paid on common stock
|
(243 | ) | (243 | ) | ||||||
|
Proceeds from exercise of stock options
|
33 | 2 | ||||||||
|
Net cash flows used in financing activities
|
(304 | ) | (1,054 | ) | ||||||
|
Net change in cash and cash equivalents
|
295 | (16 | ) | |||||||
|
Cash and cash equivalents at beginning of period
|
1,523 | 1,584 | ||||||||
|
Cash and cash equivalents at end of period
|
$ | 1,818 | $ | 1,568 | ||||||
|
Income taxes paid, net of refunds
|
$ | 33 | $ | 34 | ||||||
|
Interest paid
|
$ | 42 | $ | 77 | ||||||
|
Tobacco settlement and related expense payments
|
$ | 1,521 | $ | 1,445 | ||||||
See Notes to Condensed Consolidated Financial Statements
4
REYNOLDS AMERICAN INC.
| September 30, | December 31, | |||||||||
| 2004 | 2003 | |||||||||
| (Unaudited) | ||||||||||
|
Assets
|
||||||||||
|
Current assets:
|
||||||||||
|
Cash and cash equivalents
|
$ | 1,818 | $ | 1,523 | ||||||
|
Short-term investments
|
108 | 107 | ||||||||
|
Accounts and notes receivable, net of allowance
|
203 | 67 | ||||||||
|
Accounts receivable, related party
|
55 | | ||||||||
|
Inventories
|
1,222 | 684 | ||||||||
|
Deferred income taxes
|
926 | 713 | ||||||||
|
Other current assets
|
178 | 153 | ||||||||
|
Assets held for sale
|
98 | 84 | ||||||||
|
Total current assets
|
4,608 | 3,331 | ||||||||
|
Property, plant and equipment, net of accumulated
depreciation
|
1,139 | 894 | ||||||||
|
Trademarks, net of accumulated amortization
|
1,759 | 1,759 | ||||||||
|
Goodwill and unallocated purchase price
|
6,278 | 3,292 | ||||||||
|
Other intangibles, net of $11 amortization
|
128 | | ||||||||
|
Other assets and deferred charges
|
432 | 401 | ||||||||
| $ | 14,344 | $ | 9,677 | |||||||
|
Liabilities and shareholders
equity
|
||||||||||
|
Current liabilities:
|
||||||||||
|
Accounts payable
|
$ | 114 | $ | 36 | ||||||
|
Tobacco settlement and related accruals
|
2,319 | 1,629 | ||||||||
|
Other current liabilities
|
1,511 | 1,134 | ||||||||
|
Current maturities of long-term debt
|
50 | 56 | ||||||||
|
Liabilities related to assets held for sale
|
10 | 10 | ||||||||
|
Total current liabilities
|
4,004 | 2,865 | ||||||||
|
Long-term debt (less current maturities)
|
1,607 | 1,671 | ||||||||
|
Deferred income taxes
|
464 | 806 | ||||||||
|
Long-term retirement benefits
|
1,745 | 1,034 | ||||||||
|
Other noncurrent liabilities
|
281 | 244 | ||||||||
|
Commitments and contingencies
|
||||||||||
|
Shareholders equity:
|
||||||||||
|
Common stock (shares issued: 2004
147,433,793; 2003 116,430,211)
|
| 1 | ||||||||
|
Paid-in capital
|
8,705 | 7,377 | ||||||||
|
Accumulated deficit
|
(1,997 | ) | (2,469 | ) | ||||||
|
Accumulated other comprehensive loss
|
(465 | ) | (462 | ) | ||||||
|
Unamortized restricted stock
|
| (23 | ) | |||||||
| 6,243 | 4,424 | |||||||||
|
Less treasury stock (shares:
200331,326,603), at cost
|
| (1,367 | ) | |||||||
|
Total shareholders equity
|
6,243 | 3,057 | ||||||||
| $ | 14,344 | $ | 9,677 | |||||||
See Notes to Condensed Consolidated Financial Statements
5
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 Completed Business Combination Transactions
On July 30, 2004, R.J. Reynolds Tobacco Holdings, Inc., referred to as RJR, completed its acquisition and combination of the U.S. assets, liabilities and operations of Brown & Williamson Tobacco Corporation, referred to as B&W, a subsidiary of British American Tobacco p.l.c., referred to as BAT, with R.J. Reynolds Tobacco Company, referred to as RJR Tobacco. The combination transactions were accomplished through a new publicly traded holding company, Reynolds American Inc., referred to as RAI, with approximately 147 million shares outstanding, to hold the combined businesses. The combination transactions combined the businesses of two of the largest industry participants with strong brands, creating efficiencies and cost reductions through synergies.
RAI was incorporated in the state of North Carolina on January 5, 2004, for the purpose of facilitating the transactions to combine RJR Tobacco with the U.S. cigarette and tobacco business of B&W. As of January 20, 2004, RJR and B&W each had paid $6,500 to acquire a 50% ownership in RAI, and each had contributed additional capital of $195,500.
Coincident with completion of the combination transactions, B&W contributed a number of previously held shares to RAI, sufficient to reduce its ownership to 61,952,762 shares, or approximately 42% of RAIs common stock outstanding at the closing. The consideration assigned to the shares issued to and held by B&W was approximately $2.8 billion, or $45.882 per share, based on the average closing price of RJR common stock during the five-day period beginning two days before and ending two days after the announcement of the combination transactions. The shares of RAI previously owned by RJR were cancelled, eliminating RJRs 50% ownership of RAI. Previous RJR stockholders were issued common shares of RAI in exchange for their existing RJR shares, on a one-for-one basis, resulting in ownership of approximately 58% of RAIs common stock outstanding at the closing. No indebtedness for borrowed money of B&W was assumed by RAI. The transaction is expected to be tax-free to RJR stockholders, and is being treated as a purchase of B&W by RJR for financial accounting purposes.
As part of the combination transactions, B&W, along with its U.S. operations, transferred cash of $604 million, an amount equal to its pre-closing accrued liabilities under the Master Settlement Agreement, referred to as the MSA, and related agreements. RJR Tobacco and the U.S. cigarette and tobacco operations of B&W were combined in an indirect subsidiary of RAI, referred to as New RJR Tobacco. New RJR Tobacco, and in certain instances, RAI, have agreed to indemnify B&W and its affiliates for, among other things, all liabilities arising before or after the closing that relate to B&Ws U.S. cigarette and tobacco business. These liabilities include B&Ws historic and future tobacco-related litigation liabilities and all liabiliti